{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:48:48Z","timestamp":1785804528060,"version":"3.56.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09279-x","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T07:03:51Z","timestamp":1708585431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["COVID-19 and the brain: understanding the pathogenesis and consequences of neurological damage"],"prefix":"10.1007","volume":"51","author":[{"given":"Sumaiya Tasnim","family":"Maliha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabeya","family":"Fatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusha","family":"Araf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"issue":"4","key":"9279_CR1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s12276-021-00604-z","volume":"53","author":"D Singh","year":"2021","unstructured":"Singh D, Yi SV (2021) On the origin and evolution of SARS-CoV-2. Exp Mol Med 53(4):537\u2013547","journal-title":"Exp Mol Med"},{"issue":"2","key":"9279_CR2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mjafi.2020.04.008","volume":"76","author":"K Anand","year":"2020","unstructured":"Anand K, Karade S, Sen S, Gupta R (2020) SARS-CoV-2: camazotz\u2019s curse. Med J Armed Forces India 76(2):136\u2013141","journal-title":"Med J Armed Forces India"},{"key":"9279_CR3","volume":"12","author":"D Tian","year":"2021","unstructured":"Tian D, Sun Y, Zhou J, Ye Q (2021) The global epidemic of the SARS-CoV-2 delta variant, key spike mutations and immune escape. Front Immunol 12:751778","journal-title":"Front Immunol"},{"key":"9279_CR4","unstructured":"WHO Coronavirus (COVID-19) Dashboard: World Health Organization; 2022. https:\/\/covid19.who.int\/."},{"issue":"21","key":"9279_CR5","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.3390\/molecules26216455","volume":"26","author":"A Nassar","year":"2021","unstructured":"Nassar A, Ibrahim IM, Amin FG, Magdy M, Elgharib AM, Azzam EB et al (2021) A review of human coronaviruses\u2019 receptors: the host-cell targets for the crown bearing viruses. Molecules 26(21):6455","journal-title":"Molecules"},{"issue":"4","key":"9279_CR6","first-page":"1","volume":"2","author":"S Bittmann","year":"2020","unstructured":"Bittmann S, Weissenstein A, Mosch\u00fcring-Alieva E, Villalon G, Villalon G (2020) Neuropilin-1 in transmission process of COVID-19. J Regen Biol Med 2(4):1\u20132","journal-title":"J Regen Biol Med"},{"issue":"6518","key":"9279_CR7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370(6518):856\u2013860","journal-title":"Science"},{"issue":"6518","key":"9279_CR8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"JL Daly","year":"2020","unstructured":"Daly JL, Simonetti B, Klein K, Chen K-E, Williamson MK, Ant\u00f3n-Pl\u00e1garo C et al (2020) Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370(6518):861\u2013865","journal-title":"Science"},{"issue":"5","key":"9279_CR9","first-page":"4221","volume":"22","author":"J Davies","year":"2020","unstructured":"Davies J, Randeva HS, Chatha K, Hall M, Spandidos DA, Karteris E et al (2020) Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol Med Rep 22(5):4221\u20134226","journal-title":"Mol Med Rep"},{"issue":"1","key":"9279_CR10","volume":"17","author":"BS Mayi","year":"2021","unstructured":"Mayi BS, Leibowitz JA, Woods AT, Ammon KA, Liu AE, Raja A (2021) The role of Neuropilin-1 in COVID-19. PLoS Pathog 17(1):e1009153","journal-title":"PLoS Pathog"},{"issue":"10","key":"9279_CR11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nmeth.3541","volume":"12","author":"BA Barad","year":"2015","unstructured":"Barad BA, Echols N, Wang RY-R, Cheng Y, DiMaio F, Adams PD et al (2015) EMRinger: side chain\u2013directed model and map validation for 3D cryo-electron microscopy. Nat Methods 12(10):943\u2013946","journal-title":"Nat Methods"},{"key":"9279_CR12","first-page":"497","volume":"395","author":"K Wang","year":"2020","unstructured":"Wang K, Chen W, Zhou Y-S, Lian J-Q, Zhang Z, Du P et al (2020) SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. biorxiv 395:497","journal-title":"biorxiv"},{"issue":"1","key":"9279_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41368-019-0067-9","volume":"12","author":"H Xu","year":"2020","unstructured":"Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X et al (2020) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 12(1):1\u20135","journal-title":"Int J Oral Sci"},{"issue":"2","key":"9279_CR14","first-page":"1","volume":"2","author":"S Bittmann","year":"2020","unstructured":"Bittmann S (2020) COVID-19: The role of angiotensin-2 receptor in transmission process. J Regen Biol Med 2(2):1\u20132","journal-title":"J Regen Biol Med"},{"issue":"7","key":"9279_CR15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2013virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11(7):995\u2013998","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"9279_CR16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurol 77(6):683\u2013690","journal-title":"China JAMA Neurol"},{"issue":"13","key":"9279_CR17","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.3390\/jcm10132772","volume":"10","author":"M Gudowska-Sawczuk","year":"2021","unstructured":"Gudowska-Sawczuk M, Mroczko B (2021) The role of neuropilin-1 (NRP-1) in SARS-CoV-2 infection. J Clin Med 10(13):2772","journal-title":"J Clin Med"},{"key":"9279_CR18","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.855340","volume":"10","author":"TD Kalejaiye","year":"2022","unstructured":"Kalejaiye TD, Bhattacharya R, Burt MA, Travieso T, Okafor AE, Mou X et al (2022) SARS-CoV-2 employ BSG\/CD147 and ACE2 receptors to directly infect human induced pluripotent stem cell-derived kidney podocytes. Front Cell Dev Biol 10:855340","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"9279_CR19","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1093\/brain\/awaa240","volume":"143","author":"RW Paterson","year":"2020","unstructured":"Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T et al (2020) The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 143(10):3104\u20133120","journal-title":"Brain"},{"issue":"6","key":"9279_CR20","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/alz.12255","volume":"17","author":"GA de Erausquin","year":"2021","unstructured":"de Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S et al (2021) The chronic neuropsychiatric sequelae of COVID-19: the need for a prospective study of viral impact on brain functioning. Alzheimers Dement 17(6):1056\u20131065","journal-title":"Alzheimers Dement"},{"issue":"7868","key":"9279_CR21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","volume":"595","author":"AC Yang","year":"2021","unstructured":"Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP et al (2021) Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 595(7868):565\u2013571","journal-title":"Nature"},{"issue":"6","key":"9279_CR22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00401-021-02314-2","volume":"141","author":"R Butowt","year":"2021","unstructured":"Butowt R, Meunier N, Bryche B, von Bartheld CS (2021) The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models. Acta Neuropathol 141(6):809\u2013822","journal-title":"Acta Neuropathol"},{"issue":"5","key":"9279_CR23","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psych 8(5):416\u2013427","journal-title":"Lancet Psych"},{"issue":"2","key":"9279_CR24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M, Luciano S, Geddes JR, Harrison PJ (2021) Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psych 8(2):130\u2013140","journal-title":"Lancet Psych"},{"issue":"23","key":"9279_CR25","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","volume":"382","author":"J Helms","year":"2020","unstructured":"Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C et al (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382(23):2268\u20132270","journal-title":"N Engl J Med"},{"key":"9279_CR26","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.646908","volume":"13","author":"R Manca","year":"2021","unstructured":"Manca R, De Marco M, Ince PG, Venneri A (2021) Heterogeneity in regional damage detected by neuroimaging and neuropathological studies in older adults with COVID-19: a cognitive-neuroscience systematic review to inform the long-term impact of the virus on neurocognitive trajectories. Front Aging Neurosci 13:646908","journal-title":"Front Aging Neurosci"},{"key":"9279_CR27","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135528","volume":"742","author":"SS Mukerji","year":"2021","unstructured":"Mukerji SS, Solomon IH (2021) What can we learn from brain autopsies in COVID-19? Neurosci Lett 742:135528","journal-title":"Neurosci Lett"},{"issue":"2","key":"9279_CR28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","volume":"24","author":"J Meinhardt","year":"2021","unstructured":"Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R et al (2021) Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 24(2):168\u2013175","journal-title":"Nat Neurosci"},{"issue":"6","key":"9279_CR29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMc2011400","volume":"383","author":"VG Puelles","year":"2020","unstructured":"Puelles VG, L\u00fctgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L et al (2020) Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 383(6):590\u2013592","journal-title":"N Engl J Med"},{"issue":"7907","key":"9279_CR30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","volume":"604","author":"G Douaud","year":"2022","unstructured":"Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P et al (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604(7907):697\u2013707","journal-title":"Nature"},{"key":"9279_CR31","volume":"46","author":"S Matar-Khalil","year":"2023","unstructured":"Matar-Khalil S (2023) Neurocovid-19: efectos del COVID-19 en el cerebro. Rev Panam Salud Publica 46:e108","journal-title":"Rev Panam Salud Publica"},{"key":"9279_CR32","unstructured":"Ryan B (2022) Even mild Covid is linked to brain damage, scans show: nbcnews. https:\/\/www.nbcnews.com\/health\/health-news\/long-covid-even-mild-covid-linked-damage-brain-months-infection-rcna18959."},{"key":"9279_CR33","unstructured":"Ries J. COVID Increases Risk of Long-Term Brain Injury, Study Shows: Health. https:\/\/www.health.com\/covid-long-term-brain-injury-6747628. Accessed 05 Oct 2022"},{"key":"9279_CR34","unstructured":"Sauerwein K. COVID-19 infections increase risk of long-term brain problems: Washington University School of Medicine.: https:\/\/medicine.wustl.edu\/news\/covid-19-infections-increase-risk-of-long-term-brain-problems\/. Accessed 22 Sep 2022"},{"issue":"6","key":"9279_CR35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jamapsychiatry.2021.0500","volume":"78","author":"M Boldrini","year":"2021","unstructured":"Boldrini M, Canoll PD, Klein RS (2021) How COVID-19 affects the brain. JAMA Psychiat 78(6):682\u2013683","journal-title":"JAMA Psychiat"},{"key":"9279_CR36","volume":"19","author":"F Sarubbo","year":"2022","unstructured":"Sarubbo F, El Haji K, Vidal-Balle A, Bargay LJ (2022) Neurological consequences of COVID-19 and brain related pathogenic mechanisms: a new challenge for neuroscience. Brain, Behav Immun - Health 19:100399","journal-title":"Brain, Behav Immun - Health"},{"issue":"5","key":"9279_CR37","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030284","volume":"102","author":"S Singh","year":"2023","unstructured":"Singh S, Meher N, Mohammed A, Razab M, Bhaskar L, Nawi NM (2023) Neurological infection and complications of SARS-CoV-2: a review. Medicine 102(5):e30284","journal-title":"Medicine"},{"issue":"11","key":"9279_CR38","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/acn3.51210","volume":"7","author":"EM Liotta","year":"2020","unstructured":"Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS et al (2020) Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol 7(11):2221\u20132230","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"9279_CR39","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41582-020-0398-3","volume":"16","author":"A Pezzini","year":"2020","unstructured":"Pezzini A, Padovani A (2020) Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol 16(11):636\u2013644","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"9279_CR40","volume":"4","author":"SH Chou","year":"2021","unstructured":"Chou SH, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V et al (2021) Global incidence of neurological manifestations among patients hospitalized with COVID-19-a report for the GCS-NeuroCOVID consortium and the ENERGY consortium. JAMA Netw Open 4(5):e2112131","journal-title":"JAMA Netw Open"},{"issue":"5","key":"9279_CR41","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/acn3.51350","volume":"8","author":"EL Graham","year":"2021","unstructured":"Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C et al (2021) Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 \u201clong haulers.\u201d Ann Clin Transl Neurol 8(5):1073\u20131085","journal-title":"Ann Clin Transl Neurol"},{"key":"9279_CR42","unstructured":"Smith ZS. Covid Smell Loss Linked To Damage In Brain, Study Finds: Forbes. https:\/\/www.forbes.com\/sites\/zacharysmith\/2022\/04\/11\/covid-smell-loss-linked-to-damage-in-brain-study-finds\/?sh=45ba0f02a94c. Accessed 11 Apr 2022"},{"issue":"15","key":"9279_CR43","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/cid\/ciaa330","volume":"71","author":"A Giacomelli","year":"2020","unstructured":"Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L et al (2020) Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clin Infect Dis 71(15):889\u2013890","journal-title":"Clin Infect Dis"},{"issue":"1","key":"9279_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03200-1","volume":"24","author":"J Helms","year":"2020","unstructured":"Helms J, Kremer S, Merdji H, Schenck M, Severac F, Clere-Jehl R et al (2020) Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients. Crit Care 24(1):1\u201311","journal-title":"Crit Care"},{"key":"9279_CR45","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28633","author":"H Hussaini","year":"2022","unstructured":"Hussaini H, Rogers S, Kataria S, Uddin K, Mohamed KH, Mohamed AS et al (2022) COVID-19-induced seizures: a meta-analysis of case series and retrospective cohorts. Cureus. https:\/\/doi.org\/10.7759\/cureus.28633","journal-title":"Cureus"},{"issue":"1","key":"9279_CR46","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2021.103208","volume":"43","author":"GS Daher","year":"2022","unstructured":"Daher GS, Nassiri AM, Vanichkachorn G, Carlson ML, Neff BA, Driscoll CL (2022) New onset tinnitus in the absence of hearing changes following COVID-19 infection. Am J Otolaryngol 43(1):103208","journal-title":"Am J Otolaryngol"},{"issue":"11","key":"9279_CR47","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan. China jama 323(11):1061\u20131069","journal-title":"China jama"},{"issue":"11","key":"9279_CR48","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s00415-020-09990-2","volume":"267","author":"M Ghannam","year":"2020","unstructured":"Ghannam M, Alshaer Q, Al-Chalabi M, Zakarna L, Robertson J, Manousakis G (2020) Neurological involvement of coronavirus disease 2019: a systematic review. J Neurol 267(11):3135\u20133153","journal-title":"J Neurol"},{"key":"9279_CR49","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2020.100732","volume":"37","author":"M Mardani","year":"2020","unstructured":"Mardani M, Nadji SA, Sarhangipor KA, Sharifi-Razavi A, Baziboroun M (2020) COVID-19 infection recurrence presenting with meningoencephalitis. New Microbes New Infect 37:100732","journal-title":"New Microbes New Infect"},{"key":"9279_CR50","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fpubh.2020.00474","volume":"8","author":"S Naz","year":"2020","unstructured":"Naz S, Hanif M, Haider MA, Ali MJ, Ahmed MU, Saleem S (2020) Meningitis as an initial presentation of COVID-19: a case report. Front Public Health 8:474","journal-title":"Front Public Health"},{"issue":"2","key":"9279_CR51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.identj.2021.05.006","volume":"72","author":"NH Al-Rawi","year":"2022","unstructured":"Al-Rawi NH, Sammouda AR, AlRahin EA, Al Ali FA, Al Arayedh GS, Daryanavard HA et al (2022) Prevalence of anosmia or ageusia in patients with COVID-19 among United Arab Emirates population. Int Dent J 72(2):249\u2013256","journal-title":"Int Dent J"},{"key":"9279_CR52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jpsychires.2020.07.042","volume":"130","author":"R Noone","year":"2020","unstructured":"Noone R, Cabassa JA, Gardner L, Schwartz B, Alpert JE, Gabbay V (2020) New onset psychosis and mania following COVID-19 infection. J Psychiatr Res 130:177","journal-title":"J Psychiatr Res"},{"issue":"9","key":"9279_CR53","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1161\/STROKEAHA.120.030995","volume":"51","author":"A Rothstein","year":"2020","unstructured":"Rothstein A, Oldridge O, Schwennesen H, Do D, Cucchiara BL (2020) Acute cerebrovascular events in hospitalized COVID-19 patients. Stroke 51(9):e219\u2013e222","journal-title":"Stroke"},{"issue":"3","key":"9279_CR54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/jcm11030605","volume":"11","author":"ML Schmidbauer","year":"2022","unstructured":"Schmidbauer ML, Ferse C, Salih F, Klingner C, Musleh R, Kunst S et al (2022) COVID-19 and intracranial hemorrhage: a multicenter case series, systematic review and pooled analysis. J Clin Med 11(3):605","journal-title":"J Clin Med"},{"issue":"2","key":"9279_CR55","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271\u2013280","journal-title":"Cell"},{"issue":"2","key":"9279_CR56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/vaccines10020232","volume":"10","author":"C de Gregorio","year":"2022","unstructured":"de Gregorio C, Colarusso L, Calcaterra G, Bassareo PP, Ieni A, Mazzeo AT et al (2022) Cerebral venous sinus thrombosis following COVID-19 vaccination: analysis of 552 Worldwide cases. Vaccines 10(2):232","journal-title":"Vaccines"},{"issue":"2","key":"9279_CR57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181(2):281\u201392.e6","journal-title":"Cell"},{"issue":"1","key":"9279_CR58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10571-020-00915-1","volume":"42","author":"J Xu","year":"2022","unstructured":"Xu J, Lazartigues E (2022) Expression of ACE2 in human neurons supports the neuro-invasive potential of COVID-19 virus. Cell Mol Neurobiol 42(1):305\u2013309","journal-title":"Cell Mol Neurobiol"},{"key":"9279_CR59","doi-asserted-by":"crossref","unstructured":"Shang J, Ye G, Shi K, Wan Y, Aihara H, Li F (2020) Structure of 2019-nCoV chimeric receptor-binding domain complexed with its receptor human ACE2. Worldw Protein Data Bank.","DOI":"10.2210\/pdb6vw1\/pdb"},{"issue":"2","key":"9279_CR60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3988\/jcn.2022.18.2.194","volume":"18","author":"YMT Siahaan","year":"2022","unstructured":"Siahaan YMT, Puspitasari V, Pangestu A (2022) COVID-19-associated encephalopathy: systematic review of case reports. J Clin Neurol (Seoul, Korea) 18(2):194\u2013206","journal-title":"J Clin Neurol (Seoul, Korea)"},{"key":"9279_CR61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cnp.2020.06.001","volume":"5","author":"LJW Canham","year":"2020","unstructured":"Canham LJW, Staniaszek LE, Mortimer AM, Nouri LF, Kane NM (2020) Electroencephalographic (EEG) features of encephalopathy in the setting of Covid-19: a case series. Clin Neurophysiol Pract 5:199\u2013205","journal-title":"Clin Neurophysiol Pract"},{"key":"9279_CR62","volume":"11","author":"H Yu","year":"2020","unstructured":"Yu H, Sun T, Feng J (2020) Complications and pathophysiology of COVID-19 in the nervous system. Front Neurol 11:573421","journal-title":"Front Neurol"},{"issue":"4","key":"9279_CR63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1747493020921664","volume":"15","author":"G Aggarwal","year":"2020","unstructured":"Aggarwal G, Lippi G, Michael HB (2020) Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke 15(4):385\u2013389","journal-title":"Int J Stroke"},{"key":"9279_CR64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","volume":"191","author":"C Lodigiani","year":"2020","unstructured":"Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T et al (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis Res 191:9\u201314","journal-title":"Thrombosis Res"},{"key":"9279_CR65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM et al (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 191:148\u2013150","journal-title":"Thromb Res"},{"issue":"1","key":"9279_CR66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10072-021-05679-0","volume":"43","author":"X Tang","year":"2022","unstructured":"Tang X, Zheng F (2022) A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 43(1):67\u201379","journal-title":"Neurol Sci"},{"key":"9279_CR67","volume":"77","author":"J Finsterer","year":"2022","unstructured":"Finsterer J, Scorza FA, Scorza CA, Fiorini AC (2022) Ischemic stroke in 455 COVID-19 patients. Clinics (Sao Paulo, Brazil) 77:100012","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"4","key":"9279_CR68","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00415-021-10837-7","volume":"269","author":"W Luo","year":"2022","unstructured":"Luo W, Liu X, Bao K, Huang C (2022) Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol 269(4):1731\u20131740","journal-title":"J Neurol"},{"issue":"8","key":"9279_CR69","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.3390\/ijms22084081","volume":"22","author":"GA Shehata","year":"2021","unstructured":"Shehata GA, Lord KC, Grudzinski MC, Elsayed M, Abdelnaby R, Elshabrawy HA (2021) Neurological complications of COVID-19: underlying mechanisms and management. Int J Mol Sci 22(8):4081","journal-title":"Int J Mol Sci"},{"issue":"8","key":"9279_CR70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104984","volume":"29","author":"S Dogra","year":"2020","unstructured":"Dogra S, Jain R, Cao M, Bilaloglu S, Zagzag D, Hochman S et al (2020) Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovasc Dis 29(8):104984","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"9279_CR71","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang Z, Yang Y, Liang X, Gao B, Liu M, Li W et al (2020) COVID-19 associated ischemic stroke and hemorrhagic stroke: incidence, potential pathological mechanism, and management. Front Neurol 11:571996","journal-title":"Front Neurol"},{"issue":"7798","key":"9279_CR72","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273","journal-title":"Nature"},{"issue":"6483","key":"9279_CR73","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O et al (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367(6483):1260\u20131263","journal-title":"Science"},{"issue":"6485","key":"9279_CR74","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q (2020) Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367(6485):1444\u20131448","journal-title":"Science"},{"key":"9279_CR75","unstructured":"Sriram K, Insel E, Loomba R. (2020) What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain. The Conversation."},{"issue":"14","key":"9279_CR76","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/ars.2020.8247","volume":"35","author":"AR Bourgonje","year":"2021","unstructured":"Bourgonje AR, Offringa AK, van Eijk LE, Abdulle AE, Hillebrands J-L, van der Voort PH et al (2021) N-acetylcysteine and hydrogen sulfide in coronavirus disease 2019. Antioxid Redox Signal 35(14):1207\u20131225","journal-title":"Antioxid Redox Signal"},{"key":"9279_CR77","doi-asserted-by":"publisher","DOI":"10.3756\/amtt.2220211118","author":"M Shikder","year":"2021","unstructured":"Shikder M, Ahmed KA, Al Hasib T, Ray P, Khalipha ABR, Kabir ML (2021) In-silico molecular docking and pharmaco-kinetic activity analysis of potential inhibitors against SARS-CoV-2 spike glycoproteins. Appl Microbiol: Theor Technol. https:\/\/doi.org\/10.3756\/amtt.2220211118","journal-title":"Appl Microbiol: Theor Technol"},{"key":"9279_CR78","volume":"11","author":"R Chen","year":"2021","unstructured":"Chen R, Wang K, Yu J, Howard D, French L, Chen Z et al (2021) The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol 11:573095","journal-title":"Front Neurol"},{"issue":"6","key":"9279_CR79","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.stem.2020.10.001","volume":"27","author":"L Pellegrini","year":"2020","unstructured":"Pellegrini L, Albecka A, Mallery DL, Kellner MJ, Paul D, Carter AP et al (2020) SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids. Cell Stem Cell 27(6):951\u2013961","journal-title":"Cell Stem Cell"},{"key":"9279_CR80","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2020.596439","volume":"14","author":"F Deffner","year":"2020","unstructured":"Deffner F, Scharr M, Klingenstein S, Klingenstein M, Milazzo A, Scherer S et al (2020) Histological evidence for the enteric nervous system and the choroid plexus as alternative routes of neuroinvasion by SARS-CoV2. Front Neuroanat 14:596439","journal-title":"Front Neuroanat"},{"issue":"2","key":"9279_CR81","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12035-020-02152-5","volume":"58","author":"D Bougakov","year":"2021","unstructured":"Bougakov D, Podell K, Goldberg E (2021) Multiple neuroinvasive pathways in COVID-19. Mol Neurobiol 58(2):564\u2013575","journal-title":"Mol Neurobiol"},{"key":"9279_CR82","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.594495","volume":"7","author":"F Salamanna","year":"2020","unstructured":"Salamanna F, Maglio M, Landini MP, Fini M (2020) Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med 7:594495","journal-title":"Front Med"},{"issue":"3","key":"9279_CR83","first-page":"231","volume":"9","author":"FA Rabi","year":"2020","unstructured":"Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD (2020) SARS-CoV-2 and coronavirus disease 2019: what we know so far. Pathogens (Basel, Switzerland) 9(3):231","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"9279_CR84","doi-asserted-by":"publisher","DOI":"10.2608\/lsa.202000786","author":"D Bestle","year":"2020","unstructured":"Bestle D, Heindl MR, Limburg H, Pilgram O, Moulton H, Stein DA et al (2020) TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci Alliance. https:\/\/doi.org\/10.2608\/lsa.202000786","journal-title":"Life Sci Alliance"},{"key":"9279_CR85","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104742","volume":"176","author":"B Coutard","year":"2020","unstructured":"Coutard B, Valle C, De Lamballerie X, Canard B, Seidah NG, Decroly E (2020) The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 176:104742","journal-title":"Antiviral Res"},{"issue":"1","key":"9279_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-019-2683-3","volume":"24","author":"W Ni","year":"2020","unstructured":"Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y et al (2020) Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care 24(1):1\u201310","journal-title":"Crit Care"},{"issue":"7","key":"9279_CR87","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","volume":"26","author":"A Gupta","year":"2020","unstructured":"Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS et al (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26(7):1017\u20131032","journal-title":"Nat Med"},{"issue":"1","key":"9279_CR88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-021-00267-y","volume":"18","author":"C McQuaid","year":"2021","unstructured":"McQuaid C, Brady M, Deane R (2021) SARS-CoV-2: is there neuroinvasion? Fluids Barriers CNS 18(1):1\u201321","journal-title":"Fluids Barriers CNS"},{"key":"9279_CR89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbi.2020.12.031","volume":"95","author":"SM Burks","year":"2021","unstructured":"Burks SM, Rosas-Hernandez H, Ramirez-Lee MA, Cuevas E, Talpos JC (2021) Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier? Brain Behav Immun 95:7\u201314","journal-title":"Brain Behav Immun"},{"key":"9279_CR90","first-page":"307","volume":"13","author":"L Zhou","year":"2020","unstructured":"Zhou L, Niu Z, Jiang X, Zhang Z, Zheng Y, Wang Z et al (2020) Systemic analysis of tissue cells potentially vulnerable to SARS-CoV-2 infection by the protein-proofed single-cell RNA profiling of ACE2, TMPRSS2 and Furin proteases. bioRxiv 13:307","journal-title":"bioRxiv"},{"key":"9279_CR91","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2020.04.044","volume":"437","author":"X-Y Mao","year":"2020","unstructured":"Mao X-Y, Jin W-L (2020) The COVID-19 pandemic: consideration for brain infection. Neuroscience 437:130","journal-title":"Neuroscience"},{"issue":"9","key":"9279_CR92","doi-asserted-by":"crossref","first-page":"e3102","DOI":"10.1093\/cid\/ciaa1165","volume":"73","author":"M Bellon","year":"2021","unstructured":"Bellon M, Schweblin C, Lambeng N, Cherpillod P, Vazquez J, Lalive PH et al (2021) Cerebrospinal fluid features in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription polymerase chain reaction (RT-PCR) positive patients. Clin Infect Dis 73(9):e3102\u2013e3105","journal-title":"Clin Infect Dis"},{"key":"9279_CR93","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.697079","volume":"12","author":"SD Alipoor","year":"2021","unstructured":"Alipoor SD, Mortaz E, Varahram M, Garssen J, Adcock IM (2021) The immunopathogenesis of neuroinvasive lesions of SARS-CoV-2 infection in COVID-19 patients. Front Neurol 12:697079","journal-title":"Front Neurol"},{"issue":"5","key":"9279_CR94","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3390\/ijms22052681","volume":"22","author":"MA Erickson","year":"2021","unstructured":"Erickson MA, Rhea EM, Knopp RC, Banks WA (2021) Interactions of SARS-CoV-2 with the blood\u2013brain barrier. Int J Mol Sci 22(5):2681","journal-title":"Int J Mol Sci"},{"issue":"6","key":"9279_CR95","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41577-020-0317-2","volume":"20","author":"MD Park","year":"2020","unstructured":"Park MD (2020) Macrophages: a Trojan horse in COVID-19. Nat Rev Immunol 20(6):351","journal-title":"Nat Rev Immunol"},{"key":"9279_CR96","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fmicb.2020.00214","volume":"11","author":"C-F Chiu","year":"2020","unstructured":"Chiu C-F, Chu L-W, Liao I-C, Simanjuntak Y, Lin Y-L, Juan C-C et al (2020) The mechanism of the Zika virus crossing the placental barrier and the blood-brain barrier. Front Microbiol 11:214","journal-title":"Front Microbiol"},{"key":"9279_CR97","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3389\/fmicb.2019.02158","volume":"10","author":"AR Leda","year":"2019","unstructured":"Leda AR, Bertrand L, Andras IE, El-Hage N, Nair M, Toborek M (2019) Selective disruption of the blood\u2013brain barrier by Zika virus. Front Microbiol 10:2158","journal-title":"Front Microbiol"},{"issue":"44","key":"9279_CR98","doi-asserted-by":"crossref","first-page":"27381","DOI":"10.1073\/pnas.2010470117","volume":"117","author":"Z Li","year":"2020","unstructured":"Li Z, Li X, Huang Y-Y, Wu Y, Liu R, Zhou L et al (2020) Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs. Proc Natl Acad Sci USA 117(44):27381\u201327387","journal-title":"Proc Natl Acad Sci USA"},{"key":"9279_CR99","first-page":"1221","volume":"9","author":"Z Lv","year":"2022","unstructured":"Lv Z, Cano KE, Jia L, Drag M, Huang TT, Olsen SK (2022) Targeting SARS-CoV-2 proteases for COVID-19 antiviral development. Front Chem 9:1221","journal-title":"Front Chem"},{"issue":"4","key":"9279_CR100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92(4):418\u2013423","journal-title":"J Med Virol"},{"key":"9279_CR101","volume":"19","author":"RA Khailany","year":"2020","unstructured":"Khailany RA, Safdar M, Ozaslan M (2020) Genomic characterization of a novel SARS-CoV-2. Gene Rep 19:100682","journal-title":"Gene Rep"},{"issue":"17","key":"9279_CR102","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127377","volume":"30","author":"S Ullrich","year":"2020","unstructured":"Ullrich S, Nitsche C (2020) The SARS-CoV-2 main protease as drug target. Bioorg Med Chem Lett 30(17):127377","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"9279_CR103","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/s41593-021-00926-1","volume":"24","author":"J Wenzel","year":"2021","unstructured":"Wenzel J, Lampe J, M\u00fcller-Fielitz H, Schuster R, Zille M, M\u00fcller K et al (2021) The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci 24(11):1522\u20131533","journal-title":"Nat Neurosci"},{"issue":"8","key":"9279_CR104","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.3390\/ijms23084275","volume":"23","author":"MS Mohamed","year":"2022","unstructured":"Mohamed MS, Johansson A, Jonsson J, Schi\u00f6th HB (2022) Dissecting the molecular mechanisms surrounding post-COVID-19 syndrome and neurological features. Int J Mol Sci 23(8):4275","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9279_CR105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imr.13114","volume":"311","author":"NR Natale","year":"2022","unstructured":"Natale NR, Lukens JR, Petri WA Jr (2022) The nervous system during COVID-19: caught in the crossfire. Immunol Rev 311(1):90\u2013111","journal-title":"Immunol Rev"},{"issue":"6504","key":"9279_CR106","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N et al (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369(6504):718\u2013724","journal-title":"Science"},{"issue":"6508","key":"9279_CR107","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","volume":"369","author":"PS Arunachalam","year":"2020","unstructured":"Arunachalam PS, Wimmers F, Mok CKP, Perera RA, Scott M, Hagan T et al (2020) Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369(6508):1210\u20131220","journal-title":"Science"},{"key":"9279_CR108","doi-asserted-by":"crossref","unstructured":"Gao X, Li J-L, Chen X, Ci B, Chen F, Lu N et al (2020) Reduction of neuronal activity mediated by blood-vessel regression in the brain. bioRxiv 15.262782.","DOI":"10.1101\/2020.09.15.262782"},{"issue":"5","key":"9279_CR109","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.fmre.2022.03.003","volume":"2","author":"J Chen","year":"2022","unstructured":"Chen J, Tan R, Mo Y, Zhang J (2022) The blood-brain barrier in health, neurological diseases, and COVID-19. Fundam Res 2(5):817\u2013826","journal-title":"Fundam Res"},{"issue":"1","key":"9279_CR110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41392-021-00719-9","volume":"6","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhou L, Bao L, Liu J, Zhu H, Lv Q et al (2021) SARS-CoV-2 crosses the blood\u2013brain barrier accompanied with basement membrane disruption without tight junctions alteration. Sig Transduct Target Ther 6(1):337","journal-title":"Sig Transduct Target Ther"},{"issue":"2","key":"9279_CR111","first-page":"327","volume":"34","author":"P Conti","year":"2020","unstructured":"Conti P, Ronconi G, Caraffa A, Gallenga C, Ross R, Frydas I et al (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 34(2):327\u2013331","journal-title":"J Biol Regul Homeost Agents"},{"key":"9279_CR112","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117583","volume":"250","author":"R Zhang","year":"2020","unstructured":"Zhang R, Wang X, Ni L, Di X, Ma B, Niu S et al (2020) COVID-19: melatonin as a potential adjuvant treatment. Life Sci 250:117583","journal-title":"Life Sci"},{"issue":"1\u20133","key":"9279_CR113","first-page":"21","volume":"18","author":"A Yarlagadda","year":"2021","unstructured":"Yarlagadda A, Preston SL, Jeyadhas RP, Lang AE, Hammamieh R, Clayton AH (2021) Blood-brain barrier: COVID-19, pandemics, and cytokine norms. Innov Clin Neurosci 18(1\u20133):21","journal-title":"Innov Clin Neurosci"},{"issue":"11","key":"9279_CR114","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","volume":"19","author":"J Matschke","year":"2020","unstructured":"Matschke J, L\u00fctgehetmann M, Hagel C, Sperhake JP, Schr\u00f6der AS, Edler C et al (2020) Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 19(11):919\u2013929","journal-title":"Lancet Neurol"},{"key":"9279_CR115","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","volume":"11","author":"S Bhaskar","year":"2020","unstructured":"Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS et al (2020) Cytokine storm in COVID-19\u2014immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper. Front Immunol 11:1648","journal-title":"Front Immunol"},{"key":"9279_CR116","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.105921","volume":"194","author":"V Montalvan","year":"2020","unstructured":"Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K (2020) Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg 194:105921","journal-title":"Clin Neurol Neurosurg"},{"key":"9279_CR117","volume":"8","author":"MM Almutairi","year":"2021","unstructured":"Almutairi MM, Sivandzade F, Albekairi TH, Alqahtani F, Cucullo L (2021) Neuroinflammation and its impact on the pathogenesis of COVID-19. Front Med 8:745789","journal-title":"Front Med"},{"issue":"6","key":"9279_CR118","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.23571","volume":"67","author":"Y Qq","year":"2019","unstructured":"Qq Y, Jw Z (2019) Neuroinflammation in the central nervous system: symphony of glial cells. Glia 67(6):1017\u20131035","journal-title":"Glia"},{"issue":"8","key":"9279_CR119","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3390\/ijms21082721","volume":"21","author":"F Sivandzade","year":"2020","unstructured":"Sivandzade F, Alqahtani F, Cucullo L (2020) Traumatic brain injury and blood\u2013brain barrier (BBB): underlying pathophysiological mechanisms and the influence of cigarette smoking as a premorbid condition. Int J Mol Sci 21(8):2721","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9279_CR120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-01896-0","volume":"17","author":"S Najjar","year":"2020","unstructured":"Najjar S, Najjar A, Chong DJ, Pramanik BK, Kirsch C, Kuzniecky RI et al (2020) Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation 17(1):1\u201314","journal-title":"J Neuroinflammation"},{"key":"9279_CR121","doi-asserted-by":"crossref","unstructured":"Channappanavar R, Perlman S (eds) (2017) Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Seminars in immunopathology. Springer.","DOI":"10.1007\/s00281-017-0629-x"},{"issue":"8","key":"9279_CR122","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3390\/ijms18081788","volume":"18","author":"AJ Sorby-Adams","year":"2017","unstructured":"Sorby-Adams AJ, Marcoionni AM, Dempsey ER, Woenig JA, Turner RJ (2017) The role of neurogenic inflammation in blood-brain barrier disruption and development of cerebral oedema following acute central nervous system (CNS) injury. Int J Mol Sci 18(8):1788","journal-title":"Int J Mol Sci"},{"issue":"5","key":"9279_CR123","doi-asserted-by":"crossref","first-page":"980","DOI":"10.12998\/wjcc.v8.i5.980","volume":"8","author":"W-J Yang","year":"2020","unstructured":"Yang W-J, Yang Y-N, Cai M-G, Xing Y-Q (2020) Anomalous retinal artery associated with branch retinal artery occlusion and neovascular glaucoma: a case report. World J Clin Cases 8(5):980","journal-title":"World J Clin Cases"},{"issue":"3","key":"9279_CR124","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14726","volume":"9","author":"L \u00d8stergaard","year":"2021","unstructured":"\u00d8stergaard L (2021) SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep 9(3):e14726","journal-title":"Physiol Rep"},{"key":"9279_CR125","volume":"12","author":"R Chen","year":"2021","unstructured":"Chen R, Zhang X, Gu L, Zhu H, Zhong Y, Ye Y et al (2021) New insight into neutrophils: a potential therapeutic target for cerebral ischemia. Front Immunol 12:692061","journal-title":"Front Immunol"},{"issue":"5","key":"9279_CR126","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","volume":"20","author":"MM Lamers","year":"2022","unstructured":"Lamers MM, Haagmans BL (2022) SARS-CoV-2 pathogenesis. Nat Rev Microbiol 20(5):270\u2013284","journal-title":"Nat Rev Microbiol"},{"key":"9279_CR127","unstructured":"Small NIH study reveals how immune response triggered by COVID-19 may damage the brain: NIH. https:\/\/www.nih.gov\/news-events\/news-releases\/small-nih-study-reveals-how-immune-response-triggered-covid-19-may-damage-brain. Accessed 05 July 2022"},{"key":"9279_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100639","author":"MB Malas","year":"2020","unstructured":"Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B (2020) Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. EClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100639","journal-title":"EClinicalMedicine."},{"issue":"5","key":"9279_CR129","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/bjh.16727","volume":"189","author":"A Kollias","year":"2020","unstructured":"Kollias A, Kyriakoulis KG, Dimakakos E, Poulakou G, Stergiou GS, Syrigos K (2020) Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol 189(5):846\u2013847","journal-title":"Br J Haematol"},{"issue":"4","key":"9279_CR130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/bjh.16993","volume":"190","author":"A Kollias","year":"2020","unstructured":"Kollias A, Kyriakoulis KG, Stergiou GS, Syrigos K (2020) Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications. Br J Haematol 190(4):529\u2013532","journal-title":"Br J Haematol"},{"issue":"8","key":"9279_CR131","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00134-020-06088-1","volume":"46","author":"BS Joly","year":"2020","unstructured":"Joly BS, Siguret V, Veyradier A (2020) Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Intensive Care Med 46(8):1603\u20131606","journal-title":"Intensive Care Med"},{"issue":"4","key":"9279_CR132","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1358863X21995566","volume":"26","author":"A Kollias","year":"2021","unstructured":"Kollias A, Kyriakoulis KG, Lagou S, Kontopantelis E, Stergiou GS, Syrigos K (2021) Venous thromboembolism in COVID-19: a systematic review and meta-analysis. Vasc Med 26(4):415\u2013425","journal-title":"Vasc Med"},{"issue":"3","key":"9279_CR133","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.chest.2020.11.005","volume":"159","author":"D Jim\u00e9nez","year":"2021","unstructured":"Jim\u00e9nez D, Garc\u00eda-Sanchez A, Rali P, Muriel A, Bikdeli B, Ruiz-Artacho P et al (2021) Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest 159(3):1182\u20131196","journal-title":"Chest"},{"issue":"03","key":"9279_CR134","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1055\/s-0041-1730967","volume":"5","author":"EM Mansory","year":"2021","unstructured":"Mansory EM, Srigunapalan S, Lazo-Langner A (2021) Venous thromboembolism in hospitalized critical and noncritical COVID-19 patients: a systematic review and meta-analysis. TH Open 5(03):e286\u2013e294","journal-title":"TH Open"},{"issue":"5","key":"9279_CR135","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s13311-022-01267-y","volume":"19","author":"EL Graham","year":"2022","unstructured":"Graham EL, Koralnik IJ, Liotta EM (2022) Therapeutic approaches to the neurologic manifestations of COVID-19. Neurotherapeutics 19(5):1435\u20131466","journal-title":"Neurotherapeutics"},{"issue":"9","key":"9279_CR136","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","volume":"385","author":"PR Lawler","year":"2021","unstructured":"Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC et al (2021) Therapeutic anticoagulation with heparin in noncritically Ill patients with Covid-19. N Engl J Med 385(9):790\u2013802","journal-title":"N Engl J Med"},{"key":"9279_CR137","volume":"375","author":"M Sholzberg","year":"2021","unstructured":"Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, \u00c1inle FN et al (2021) Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ (Clinical Research Ed) 375:n2400","journal-title":"BMJ (Clinical Research Ed)"},{"issue":"12","key":"9279_CR138","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","volume":"181","author":"AC Spyropoulos","year":"2021","unstructured":"Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S et al (2021) Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients With COVID-19: the HEP-COVID randomized clinical trial. JAMA Intern Med 181(12):1612\u20131620","journal-title":"JAMA Intern Med"},{"issue":"3","key":"9279_CR139","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/svn-2020-000431","volume":"5","author":"Y Li","year":"2020","unstructured":"Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y et al (2020) Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 5(3):279\u2013284","journal-title":"Stroke Vasc Neurol"},{"key":"9279_CR140","doi-asserted-by":"crossref","first-page":"107602962096079","DOI":"10.1177\/1076029620960797","volume":"26","author":"I Wijaya","year":"2020","unstructured":"Wijaya I, Andhika R, Huang I (2020) The use of therapeutic-dose anticoagulation and its effect on mortality in patients with COVID-19: a systematic review. Clin Appl Thromb Hemost 26:1076029620960797","journal-title":"Clin Appl Thromb Hemost"},{"issue":"8","key":"9279_CR141","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1161\/STROKEAHA.120.030417","volume":"51","author":"JP Broderick","year":"2020","unstructured":"Broderick JP, Elm JJ, Janis LS, Zhao W, Moy CS, Dillon CR et al (2020) National Institutes of Health StrokeNet during the time of COVID-19 and beyond. Stroke 51(8):2580\u20132586","journal-title":"Stroke"},{"issue":"8","key":"9279_CR142","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3174\/ajnr.A6644","volume":"41","author":"DD Cavalcanti","year":"2020","unstructured":"Cavalcanti DD, Raz E, Shapiro M, Dehkharghani S, Yaghi S, Lillemoe K et al (2020) Cerebral venous thrombosis associated with COVID-19. Am J Neuroradiol 41(8):1370\u20131376","journal-title":"Am J Neuroradiol"},{"key":"9279_CR143","volume":"735","author":"Y-J Li","year":"2020","unstructured":"Li Y-J, Shi SX, Liu Q, Shi F-D, Gonzales RJ (2020) Targeted role for sphingosine-1-phosphate receptor 1 in cerebrovascular integrity and inflammation during acute ischemic stroke. Neurosci Lett 735:135160","journal-title":"Neurosci Lett"},{"issue":"6","key":"9279_CR144","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psym.2020.05.013","volume":"61","author":"EB Baller","year":"2020","unstructured":"Baller EB, Hogan CS, Fusunyan MA, Ivkovic A, Luccarelli JW, Madva E et al (2020) Neurocovid: pharmacological recommendations for delirium associated with COVID-19. Psychosomatics 61(6):585\u2013596","journal-title":"Psychosomatics"},{"key":"9279_CR145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173375","volume":"883","author":"PK Samudrala","year":"2020","unstructured":"Samudrala PK, Kumar P, Choudhary K, Thakur N, Wadekar GS, Dayaramani R et al (2020) Virology, pathogenesis, diagnosis and in-line treatment of COVID-19. Eur J Pharmacol 883:173375","journal-title":"Eur J Pharmacol"},{"key":"9279_CR146","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146401","volume":"1723","author":"F Azedi","year":"2019","unstructured":"Azedi F, Mehrpour M, Talebi S, Zendedel A, Kazemnejad S, Mousavizadeh K et al (2019) Melatonin regulates neuroinflammation ischemic stroke damage through interactions with microglia in reperfusion phase. Brain Res 1723:146401","journal-title":"Brain Res"},{"key":"9279_CR147","unstructured":"Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 \/ COVID-19 Infection (PRODEX): ClinicalTrials; April 16, 2020. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04350086."},{"issue":"6","key":"9279_CR148","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.tcm.2022.04.004","volume":"32","author":"KS Hingorani","year":"2022","unstructured":"Hingorani KS, Bhadola S, Cervantes-Arslanian AM (2022) COVID-19 and the brain. Trends Cardiovasc Med 32(6):323\u2013330","journal-title":"Trends Cardiovasc Med"},{"issue":"12","key":"9279_CR149","volume":"143","author":"A Cao","year":"2020","unstructured":"Cao A, Rohaut B, Le Guennec L, Saheb S, Marois C, Altmayer V et al (2020) Severe COVID-19-related encephalitis can respond to immunotherapy. Brain 143(12):e102","journal-title":"Brain"},{"issue":"12","key":"9279_CR150","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1212\/WNL.0000000000010354","volume":"95","author":"D Pugin","year":"2020","unstructured":"Pugin D, Vargas MI, Thieffry C, Schibler M, Grosgurin O, Pugin J et al (2020) COVID-19-related encephalopathy responsive to high-dose glucocorticoids. Neurology 95(12):543\u2013546","journal-title":"Neurology"},{"key":"9279_CR151","doi-asserted-by":"publisher","DOI":"10.20517\/2347-8659.2020.61","author":"V Chenna","year":"2021","unstructured":"Chenna V, Jenjeti C, Devarapu K (2021) Use of intravenous immunoglobulin to successfully treat COVID-19 associated encephalitis. Neuroimmunol Neuroinflam. https:\/\/doi.org\/10.20517\/2347-8659.2020.61","journal-title":"Neuroimmunol Neuroinflam"},{"issue":"654","key":"9279_CR152","doi-asserted-by":"crossref","first-page":"eabo2652","DOI":"10.1126\/scitranslmed.abo2652","volume":"14","author":"AM Gusdon","year":"2022","unstructured":"Gusdon AM, Faraday N, Aita JS, Kumar S, Mehta I, Choi HA et al (2022) Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial. Sci Transl Med 14(654):eabo2652","journal-title":"Sci Transl Med"},{"issue":"1","key":"9279_CR153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-022-01087-8","volume":"31","author":"GE Batiha","year":"2023","unstructured":"Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Alruwaili M, AlRuwaili R, Albogami SM et al (2023) Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal. Inflammopharmacology 31(1):1\u20137","journal-title":"Inflammopharmacology"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09279-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09279-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09279-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:30:19Z","timestamp":1738701019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09279-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9279"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09279-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"assertion":[{"value":"8 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}],"article-number":"318"}}